Hem › Mantelcellslymfom › Virginia › Charlottesville
Kliniska studier för Mantelcellslymfom i Charlottesville, VA
4 studier för Mantelcellslymfom söker deltagare vid platser i och runt Charlottesville (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RekryterarFas 3
- University of Virginia, Charlottesville
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
RekryterarFas 2
- University of Virginia Cancer Center, Charlottesville
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
RekryterarFas 1/2
- University of Virginia Cancer Center, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Charlottesville
Mantelcellslymfom-studier i andra städer
- Baldwin Park, CA15 studier
- Houston, TX15 studier
- Durham, NC13 studier
- New York City, NY12 studier
- Milwaukee, WI12 studier
- Seattle, WA12 studier
- Boston, MA11 studier
- Columbus, OH11 studier
- Nashville, TN11 studier
- Chicago, IL10 studier
- Portland, OR9 studier
- Rochester, MN9 studier
Andra studier i Charlottesville
- Icke-småcellig lungcancer21 studier
- Akut myeloid leukemi16 studier
- Prostatacancer15 studier
- Metastaserande cancer13 studier
- Endometriecancer13 studier
- Cancer (alla typer)13 studier
- Lungcancer13 studier
- Hjärtsvikt11 studier
- Äggstockscancer10 studier
- Kolorektal cancer10 studier
- Typ 1-diabetes9 studier
- Bröstcancer9 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.